Aptevo Therapeutics Statistics
Total Valuation
APVO has a market cap or net worth of $474,835. The enterprise value is -$11.04 million.
| Market Cap | 474,835 |
| Enterprise Value | -11.04M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
APVO has 673,430 shares outstanding. The number of shares has increased by 139.76% in one year.
| Shares Outstanding | 673,430 |
| Shares Change (YoY) | +139.76% |
| Shares Change (QoQ) | -2.74% |
| Owned by Insiders (%) | 0.11% |
| Owned by Institutions (%) | 1.23% |
| Float | 531,859 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.04 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.44.
| Current Ratio | 2.64 |
| Quick Ratio | n/a |
| Debt / Equity | 0.44 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -104.80% and return on invested capital (ROIC) is -163.91%.
| Return on Equity (ROE) | -104.80% |
| Return on Assets (ROA) | -60.10% |
| Return on Capital (ROIC) | -163.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$435,275 |
| Employee Count | 40 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -99.23% in the last 52 weeks. The beta is 4.93, so APVO's price volatility has been higher than the market average.
| Beta (1Y) | 4.93 |
| 52-Week Price Change | -99.23% |
| 50-Day Moving Average | 4.23 |
| 200-Day Moving Average | 13.10 |
| Relative Strength Index (RSI) | 21.74 |
| Average Volume (30 Days) | 281,897 |
Short Selling Information
The latest short interest is 145,614, so 21.62% of the outstanding shares have been sold short.
| Short Interest | 145,614 |
| Short Previous Month | 34,256 |
| Short % of Shares Out | 21.62% |
| Short % of Float | 27.38% |
| Short Ratio (days to cover) | 0.32 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.88M |
| Pretax Income | -17.41M |
| Net Income | -17.41M |
| EBITDA | -16.84M |
| EBIT | -17.41M |
| Earnings Per Share (EPS) | -$62.48 |
Balance Sheet
The company has $16.90 million in cash and $5.40 million in debt, giving a net cash position of $11.51 million or $17.09 per share.
| Cash & Cash Equivalents | 16.90M |
| Total Debt | 5.40M |
| Net Cash | 11.51M |
| Net Cash Per Share | $17.09 |
| Equity / Book Value | 12.22M |
| Book Value Per Share | 18.15 |
| Working Capital | 11.84M |
Cash Flow
| Operating Cash Flow | -11.73M |
| Capital Expenditures | n/a |
| Free Cash Flow | -11.73M |
| FCF Per Share | -$42.19 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APVO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -139.76% |
| Shareholder Yield | -139.76% |
| Earnings Yield | -3,760.61% |
| FCF Yield | -2,533.57% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on March 6, 2024. It was a reverse split with a ratio of 1:44.
| Last Split Date | Mar 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:44 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |